| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 04/11/2020 | 22:01 | GlobeNewswire Inc. | OraSure Technologies, Inc. Announces Third Quarter 2020 Financial Results and Provides Update on COVID-19 Developments | NASDAQ:OSUR | OraSure Technologies Inc |
| 03/11/2020 | 13:00 | GlobeNewswire Inc. | OraSure’s DNA Genotek Subsidiary Receives FDA Emergency Use Authorization for its ORAcollect®·RNA Saliva Collection Devic... | NASDAQ:OSUR | OraSure Technologies Inc |
| 21/10/2020 | 12:00 | GlobeNewswire Inc. | OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call Wednesday, November 4, 2020, 5:00 p.m. ET | NASDAQ:OSUR | OraSure Technologies Inc |
| 19/10/2020 | 12:00 | GlobeNewswire Inc. | OraSure’s OMNIgene®·ORAL Collection Device Receives FDA Emergency Use Authorization for SARS CoV-2 | NASDAQ:OSUR | OraSure Technologies Inc |
| 28/09/2020 | 22:59 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OSUR | OraSure Technologies Inc |
| 24/09/2020 | 12:00 | GlobeNewswire Inc. | OraSure’s ORAcollect®·RNA Device Included in EUA Granted to Quadrant Biosciences Inc. for COVID-19 Test | NASDAQ:OSUR | OraSure Technologies Inc |
| 15/09/2020 | 18:00 | GlobeNewswire Inc. | Former CEO of H2O+ Beauty, Former Chief Chemist of MAC Cosmetics Launch Innovative Skincare Brand Using First-Ever Scientific... | NASDAQ:OSUR | OraSure Technologies Inc |
| 09/09/2020 | 19:02 | Dow Jones News | Correction to Rapid Covid-19 Tests Article (Sept. 8) | NASDAQ:OSUR | OraSure Technologies Inc |
| 03/09/2020 | 22:30 | GlobeNewswire Inc. | OraSure’s ORAcollect®·RNA Device Included in EUA Granted to MiraDx Inc. for SARS-CoV-2 Test | NASDAQ:OSUR | OraSure Technologies Inc |
| 01/09/2020 | 12:00 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OSUR | OraSure Technologies Inc |
| 27/08/2020 | 22:30 | GlobeNewswire Inc. | OraSure Technologies to Present at Upcoming Investor Conferences | NASDAQ:OSUR | OraSure Technologies Inc |
| 26/08/2020 | 22:31 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:OSUR | OraSure Technologies Inc |
| 10/08/2020 | 22:59 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OSUR | OraSure Technologies Inc |
| 05/08/2020 | 22:01 | GlobeNewswire Inc. | OraSure Technologies, Inc. Announces 2020 Second Quarter Financial Results and Update on COVID-19 Testing Programs | NASDAQ:OSUR | OraSure Technologies Inc |
| 31/07/2020 | 18:15 | GlobeNewswire Inc. | OraSure’s OMNIgene®·ORAL Device Included in EUA Granted to Clinical Reference Laboratory for Self-Collected SARS-CoV-2 S... | NASDAQ:OSUR | OraSure Technologies Inc |
| 31/07/2020 | 17:23 | PR Newswire (US) | Clinical Reference Laboratory Receives FDA Emergency Use Authorization for Best-in-Class Self-Collected COVID-19 Saliva Test | NASDAQ:OSUR | OraSure Technologies Inc |
| 22/07/2020 | 12:00 | GlobeNewswire Inc. | OraSure Technologies to Hold Second Quarter 2020 Earnings Conference Call on August 5th, 2020 | NASDAQ:OSUR | OraSure Technologies Inc |
| 25/06/2020 | 14:00 | GlobeNewswire Inc. | Diversigen, Inc. and Alimentiv Inc. Announce Collaboration Agreement for Ulcerative Colitis Research Study | NASDAQ:OSUR | OraSure Technologies Inc |
| 17/06/2020 | 13:00 | GlobeNewswire Inc. | OraSure’s DNA Genotek Subsidiary Unveils First In-Home Self-Collection Device for Metabolomics | NASDAQ:OSUR | OraSure Technologies Inc |
| 17/06/2020 | 13:00 | PR Newswire (US) | Metabolon, Inc. and DNA Genotek Collaborate on First Ambient-Temperature Microbiome Sampling Solution for Metabolomics | NASDAQ:OSUR | OraSure Technologies Inc |
| 10/06/2020 | 14:00 | GlobeNewswire Inc. | OraSure Technologies Receives BARDA Funding for Coronavirus Antibody ELISA Using Oral Fluid Samples | NASDAQ:OSUR | OraSure Technologies Inc |
| 08/06/2020 | 14:00 | GlobeNewswire Inc. | OraSure’s Oragene®•Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test | NASDAQ:OSUR | OraSure Technologies Inc |
| 04/06/2020 | 02:50 | GlobeNewswire Inc. | OraSure Technologies, Inc. Announces Exercise of Option to Purchase Additional Shares of Common Stock | NASDAQ:OSUR | OraSure Technologies Inc |
| 03/06/2020 | 23:19 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:OSUR | OraSure Technologies Inc |
| 03/06/2020 | 05:15 | GlobeNewswire Inc. | OraSure Technologies, Inc. Prices Underwritten Offering of Common Stock | NASDAQ:OSUR | OraSure Technologies Inc |
| 02/06/2020 | 22:50 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:OSUR | OraSure Technologies Inc |
| 01/06/2020 | 22:01 | GlobeNewswire Inc. | OraSure Technologies, Inc. Announces Proposed Public Offering of Common Stock | NASDAQ:OSUR | OraSure Technologies Inc |
| 29/05/2020 | 12:00 | GlobeNewswire Inc. | OraSure Technologies Appoints Lelio Marmora to Board of Directors | NASDAQ:OSUR | OraSure Technologies Inc |
| 26/05/2020 | 12:00 | GlobeNewswire Inc. | OraSure Technologies to Present at the Jefferies 2020 Healthcare Conference | NASDAQ:OSUR | OraSure Technologies Inc |
| 22/05/2020 | 13:00 | GlobeNewswire Inc. | OraSure’s OMNIgene®·ORAL Kit Included in EUA Granted to P23 Labs for At-Home Collection of Saliva Samples for SARS-CoV-2... | NASDAQ:OSUR | OraSure Technologies Inc |